These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16105023)

  • 21. Renal tubulointerstitial injury from ureteral obstruction in the neonatal rat is attenuated by IGF-1.
    Chevalier RL; Goyal S; Kim A; Chang AY; Landau D; LeRoith D
    Kidney Int; 2000 Mar; 57(3):882-90. PubMed ID: 10720941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD44v3-v10 reduces the profibrotic effects of TGF-β1 and attenuates tubular injury in the early stage of chronic obstructive nephropathy.
    Rampanelli E; Rouschop K; Teske GJ; Claessen N; Leemans JC; Florquin S
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1445-54. PubMed ID: 24026183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obstructive nephropathy in the neonatal rat is attenuated by epidermal growth factor.
    Chevalier RL; Goyal S; Wolstenholme JT; Thornhill BA
    Kidney Int; 1998 Jul; 54(1):38-47. PubMed ID: 9648061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perinatal obstructive nephropathy.
    Chevalier RL
    Semin Perinatol; 2004 Apr; 28(2):124-31. PubMed ID: 15200251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opposite role of CD44-standard and CD44-variant-3 in tubular injury and development of renal fibrosis during chronic obstructive nephropathy.
    Rampanelli E; Rouschop KM; Claessen N; Teske GJ; Pals ST; Leemans JC; Florquin S
    Kidney Int; 2014 Sep; 86(3):558-69. PubMed ID: 24717295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal vascular endothelial growth factor in neonatal obstructive nephropathy. II. Exogenous VEGF.
    Burt LE; Forbes MS; Thornhill BA; Kiley SC; Minor JJ; Chevalier RL
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F168-74. PubMed ID: 16788139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy.
    Wang X; Zhou Y; Tan R; Xiong M; He W; Fang L; Wen P; Jiang L; Yang J
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F973-82. PubMed ID: 20844022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice.
    Lange-Sperandio B; Cachat F; Thornhill BA; Chevalier RL
    Kidney Int; 2002 Feb; 61(2):516-24. PubMed ID: 11849391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AT1 receptor blockade prevents interstitial and glomerular apoptosis but not fibrosis in pigs with neonatal induced partial unilateral ureteral obstruction.
    Eskild-Jensen A; Paulsen LF; Wogensen L; Olesen P; Pedersen L; Frøkiaer J; Nyengaard JR
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1771-81. PubMed ID: 17356126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and cellular pathophysiology of obstructive nephropathy.
    Chevalier RL
    Pediatr Nephrol; 1999 Sep; 13(7):612-9. PubMed ID: 10460514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Losartan attenuates renal interstitial fibrosis and tubular cell apoptosis in a rat model of obstructive nephropathy.
    He P; Li D; Zhang B
    Mol Med Rep; 2014 Aug; 10(2):638-44. PubMed ID: 24912579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Modulation of aberrant extracellular matrix degradation systems by astragali radix and angelicae sinensis radix decoction (A&A) in interstitial fibrotic kidney].
    Meng L; Liao A; Qu L; Tang J; Li X
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):79-84. PubMed ID: 22741467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo bradykinin B2 receptor activation reduces renal fibrosis.
    Schanstra JP; Neau E; Drogoz P; Arevalo Gomez MA; Lopez Novoa JM; Calise D; Pecher C; Bader M; Girolami JP; Bascands JL
    J Clin Invest; 2002 Aug; 110(3):371-9. PubMed ID: 12163456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy.
    Gao X; Mae H; Ayabe N; Takai T; Oshima K; Hattori M; Ueki T; Fujimoto J; Tanizawa T
    Kidney Int; 2002 Oct; 62(4):1238-48. PubMed ID: 12234294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice.
    Matsuo S; López-Guisa JM; Cai X; Okamura DM; Alpers CE; Bumgarner RE; Peters MA; Zhang G; Eddy AA
    Kidney Int; 2005 Jun; 67(6):2221-38. PubMed ID: 15882265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific molecular targeting of renal injury in obstructive nephropathy.
    Chevalier RL
    Kidney Int; 2006 Oct; 70(7):1200-1. PubMed ID: 16988728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage infiltration and renal damage are independent of matrix metalloproteinase 12 in the obstructed kidney.
    Abraham AP; Ma FY; Mulley WR; Ozols E; Nikolic-Paterson DJ
    Nephrology (Carlton); 2012 May; 17(4):322-9. PubMed ID: 22257277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy.
    Huuskes BM; Wise AF; Cox AJ; Lim EX; Payne NL; Kelly DJ; Samuel CS; Ricardo SD
    FASEB J; 2015 Feb; 29(2):540-53. PubMed ID: 25395452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
    Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
    J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of low-dose carbon monoxide against renal fibrosis induced by unilateral ureteral obstruction.
    Wang L; Lee JY; Kwak JH; He Y; Kim SI; Choi ME
    Am J Physiol Renal Physiol; 2008 Mar; 294(3):F508-17. PubMed ID: 18094035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.